Navigation Links
Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA
Date:6/3/2011

SAN DIEGO, June 3, 2011 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave® (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.  Orexigen sought the meeting to gain clarity on the approval deficiency stated in the Complete Response letter the Company received on January 31, 2011.  The Complete Response letter requested that the Company conduct a randomized, double-blind, placebo-controlled trial of sufficient size and duration to demonstrate that the risk of major adverse cardiovascular events in overweight and obese subjects treated with Contrave does not adversely affect the drug's benefit-risk profile.  

Orexigen submitted a specific proposal to address the theoretical cardiovascular risk cited in the approval deficiency and also explored approval for a narrowed indication in patients with lower cardiovascular risk until data from the proposed outcomes trial could be reviewed for label expansion.  The Division of Metabolic and Endocrinologic Products (DMEP) advised Orexigen that the proposed cardiovascular outcomes trial would not adequately address the approval deficiency and instead, requested a pre-approval cardiovascular outcomes trial that Orexigen believes is unprecedented and would generate significantly more information than is necessary or feasible.  Additionally, DMEP stated that it would not consider approving Contrave for a narrowed population without first reviewing data from a cardiovascular outcomes trial.  Finally, DMEP said that it intends to hold a general advisory committee early next year to discuss cardiovascular assessment for obesity therapeutics, and that any agreement reached on the desi
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
2. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
3. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
7. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
11. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... The Physician-Patient Alliance for Health & ... 2015, "Surviving Your Hospital Stay: Physician-Patient Alliance for ... A sentence was omitted from the ... "PPAHS is a member of the National Coalition to ... on the National Coalition to Promote Continuous Monitoring of ...
(Date:7/31/2015)... July 31, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... its previously announced underwritten public offering of 7,666,667 ... offering price of $11.25 per share. The shares ... shares issued upon the exercise in full by ...
(Date:7/31/2015)... July 31, 2015 Magnaquest, ... video, data and cloud computing operators has signed ... pharma giant for Internet of Things (IoT) related ... offered on subscription model.      (Logo: ... is striving for business innovations to make healthcare ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... 11, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: ... emerging leader in the development, assembly, marketing and sale ... today announced that it will hold a conference call ... nine months ended September 30, 2010. The conference call ...
... According to Millennium Research Group (MRG), the global authority on ... CVIS market is largely a replacement market, there are key ... United Kingdom and France. In the UK, the ... Project in 2013 presents a large opportunity for radiology PACS ...
Cached Medicine Technology:Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results 2European PACS Market To Attain $512M by 2015 2
(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 ... patients and family members, medical professionals, and researchers, covering a variety of topics ... is a collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... “HARMONY 2015”, one of the industry’s premier thought leadership symposiums, hosted by ... and 6. The event attracts over 250 “C”-level executives, administrators, directors of ...
(Date:7/31/2015)... ... 31, 2015 , ... The Mount Sinai Health System will work with Columbia ... of related, experimental treatments. The collaboration moves into the next phase with the recent ... of five state licenses to produce and dispense medical marijuana. , Mount Sinai ...
(Date:7/31/2015)... ... 2015 , ... Like nearly every other form of surgery, it shouldn't come ... effective and less intrusive and painful. Leading these advances in the United States ... currently stands as the only doctor in the United States who is qualified to ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased ... until a heart rate of 150 beats versus 100 beats, this is a big ... able to give life back to patients with heart disease," he adds. People with ...
Breaking Medicine News(10 mins):Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... Children Learning All Summer Long , ... Salt Lake City, UT (PRWEB) ... the popular Signing Time DVD series and hit public television ... communicate using American Sign Language (ASL) – is pleased to announce the ...
... of the Park Avenue Laser Vision (PALV) Center recently appeared ... a featured guest to discuss the issue of offering his ... the popular video sharing site, YouTube. Dr. Chynn explains ... a way to reach people in their 20s, 30s, and ...
... and soccer players who have had a previous concussion ... of concussion, new research released today at the 2008 ... the JW Marriott Orlando Grande Lakes shows. The study ... for significant differences in test results following the injury. ...
... the only brand,of diabetic socks available anywhere in the ... a Five Year Extended Warranty, has new owners and,is ... ) is pleased,to announce its April 1st 2008 acquisition ... to the UK via the website:, http://www.SmoothToe.co.uk ., ...
... The Pharmaceutical Care,Management Association (PCMA) released the ... which includes a provision that requires,physicians to use ... of an e-prescribing requirement in Medicare is a ... e-prescribing,is the most important issue in the Medicare ...
... Includes Three Provisions That Protect Patient Access ... The U.S. Senate,today voted by unanimous ... Medicare,Improvement for Patients and Providers Act of ... accelerated reimbursements for,Medicare Part D claims, delayed ...
Cached Medicine News:Health News:Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 3Health News:Men and women with history of concussion mend differently, study finds 2Health News:SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group 2
... A C. difficile Rapid Toxin A Test gives ... 10 minutes. When it might be C. difficile, ... that performs only a few tests a day ... for testing, ColorPAC Toxin A C. difficile Rapid ...
... aids should not suffice, then electronic magnification comes ... television set today. With an electronic television reader, ... to 70 times. A video camera shows a ... television monitor. The television reader has been especially ...
... Slit-Lamp. Rechargeable, cordless slit-lamp ... any purpose , Easy selection of ... filter , Extra-bright halogen lamp light ... and extra ,power pack , Supports ...
... Wave combines three advanced technologies - ... easy-to-use refractive diagnostic workstation. Now, with ... refraction, corneal topography, optical path difference ... Wave allows you to evaluate your ...
Medicine Products: